The following represents disclosure information provided by authors of this abstract. The ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer Planning Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The analytic validation of prostate-specific mRNA detection in whole blood by RT-PCR as a prognostic biomarker for patients with castration-resistant prostate cancer (CRPC).
Daniel Costin Danila
No relevant relationships to disclose
Aseem Anand
No relevant relationships to disclose
Glenn Heller
No relevant relationships to disclose
Mingliang Wan
No relevant relationships to disclose
Matthew Zehnder
No relevant relationships to disclose
Raya Khanin
No relevant relationships to disclose
Nikolaus Schultz
No relevant relationships to disclose
Martin Fleisher
No relevant relationships to disclose
Hans Lilja
No relevant relationships to disclose
Howard I. Scher
No relevant relationships to disclose